Oura to Acquire Counsel Health for $625 Million in Cash
Smart ring maker Oura has entered into a definitive agreement to acquire AI platform Counsel Health. The $625 million transaction is expected to close by the end of 2026.
Oura is acquiring Counsel Health for $625 million in cash. On November 10, 2026, the companies announced a definitive agreement, which Oura expects to close by the end of the 2026 calendar year. The transaction remains subject to customary closing conditions.
Counsel operates an AI platform for primary care that licensed physicians can participate in. The companies have worked together since May 2026. After the acquisition is completed, Counsel is expected to continue serving existing and new enterprise partners, including health plans and healthcare systems.
Oura Acquires Counsel Health and Expands Its Focus
The agreement represents a shift for Oura from consumer biometric tracking toward clinical care services using AI and physicians. Oura is best known for the Oura Ring, which collects data related to the user’s health and physiological functions.
The company also points out that the Oura Ring is not a medical device and is not intended to diagnose, treat, or prevent disease. This boundary remains important as wearable-device data is planned to be connected with Counsel’s services.
What Has Been Confirmed So Far
- The purchase price is $625 million in cash.
- This is a definitive agreement, not a completed transaction.
- Closing is expected by the end of 2026, if customary conditions are met.
- Counsel is expected to continue providing services to enterprise partners, health plans, and healthcare systems.
- The Oura and Counsel partnership has been operating since May 2026.
Questions Around Integration and Data
The companies say the combination is intended to help with earlier identification of health problems, access to care, and costs. However, these benefits currently represent the companies’ expectations, not independently verified results.
The announcement does not specify which features will be added to the Oura app, in which countries they will be available, how much they will cost, or what rules will apply to the sharing of health data. Details about physician availability in individual areas also remain unclear.
When continuous wearable-device data, medical AI, and physician care are connected, information about clinical safety, the quality of AI decisions, privacy protection, and users’ informed consent will be important. Regulatory requirements related to providing healthcare and processing sensitive health data may also be relevant.
What to Watch Next
The next step will be confirmation that the deal has closed or, potentially, an announcement of a delay or change in its terms. After that, it will be important to see what details Oura and Counsel disclose about service integration, pricing, geographic coverage, access to physicians, and the handling of health data.
Sources
- Oura – Oura confirms the definitive acquisition agreement, the previous partnership dating back to May 2026, and the expected year-end closing.
- Counsel Health – newsroom – Counsel states the $625 million cash price, closing conditions, continued service for enterprise partners, and the notice that the Oura Ring is not a medical device.
- Reuters – Independently confirms that this is a $625 million cash acquisition of a virtual primary care company.
Verified and updated: November 11, 2026 06:52
